Aortic Stenosis Flashcards

1
Q

where is the aortic valve auscultated

A

in the right upper sternal border; right sternal border at the 2nd intercostal space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is aortic stenosis

A

progressive narrowing of the aorta causing obstruction of blood flow through the aortic valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what causes the narrowing and obstruction of the aortic valve

A

aortic valve fibrosis and calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

aetiology of aortic stenosis (greatest cause)

A

congenital bicuspid aortic valve calcification is the greatest cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

other causes of aortic stenosis

A

stenosis can be secondary to rheumatic heart disease.

it can also be due to calcification and degeneration of tricuspid aortic valve in the elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

risk factors of aortic stenosis

A
age above 60 yrs
congenital bicuspid aortic valve
rheumatic heart disease
chronic kidney disease (calcium levels)
radiotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is bicuspid aortic valve

A

the aortic valve usually has 3 leaflets, in congenital BAC, there are only 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

epidemiology of aortic stenosis

A

presents in 3% of people aged 75 and above

more common in males

those with BAV will present with it earlier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

presenting symptoms of aortic stenosis

A

may initially be asymptomatic, extertional dyspnoea (breathlessness on exercise), angina, syncope or dizziness, fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why can someone present with angina

A

hypertrophic left ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why may someone present with syncope or dizziness

A

outflow obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why may someone present with fatigue

A

less O2 reaching tissues and muscles, less aerobic respiration and therefore less ATP generation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

signs upon physical examination

A

ejection systolic murmur in the aortic region, S2 will be diminished- it will either be softened or absent, narrow pulse pressure, thrill in aortic area and forceful sustained thrusting undisplaced apex beat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what nature is the murmur

A

crescendo-descrendo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what investigations will be done

A

Transthoracic echocardiogram
ECG
chest XRay
cardiac angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what ECG findings are most common

A

mostly present with LVH abnormalities; deep S wave in V1/2, tall R in V5/6 and T inversion in lead I, aVL and V5/6

17
Q

What other diseases can manifest on an ECG in someone with aortic stenosis

A

Patients with AS can often have conduction disease manifesting as atrioventricular block, hemiblock, or bundle branch block

18
Q

initial treatment

A

medical therapy or balloon valvuloplasty

19
Q

acute treatment

A

surgical/ trans catheter valve replacement

with long term infective endocarditis antibiotic prophylaxis, long term anticoagulation and medical therapy

20
Q

what else will be given to someone that’s had surgical/transcatheter replacement of the aortic valve

A

long term infective endocarditis antibiotic prophylaxis, long term anticoagulation and medical therapy

21
Q

what does medical therapy include

A

Medical therapy for hypertension and hyperlipidaemia is appropriate in patients with AS and hypertension and/or coronary artery disease

Statin therapy is indicated for primary and secondary prevention of atherosclerosis in all patients with calcific AS on the basis of standard risk scores

In patients who have undergone TAVR, renin–angiotensin system blocker therapy (ACE inhibitor or angiotensin receptor blocker) may be considered to reduce the long-term risk of all-cause mortality